1,152 material Form 8-K filings that 918 companies we cover made with the SEC in October 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
BrightSpring Health Services reported preliminary third-quarter 2025 results for continuing operations, with revenue of approximately $3,334 million, up 28.2%, and Adjusted EBITDA of approximately $160 million, up 37.2%. The company raised its full-year 2025 revenue and Adjusted EBITDA guidance, which excludes the pending Community Living divestiture to Sevita. The results are preliminary, and full third-quarter results will be announced on October 28, 2025.
Q3 2025 revenue of approximately $3,334 million, up 28.2% from approximately $2,601 million; Adjusted EBITDA of approximately $160 million, up 37.2% from approximately $117 million.
Q3 2025 net income of approximately $37.5 million, compared with a net loss of approximately $25.7 million in Q3 2024.
2025 revenue guidance raised to $12,400 million to $12,700 million; Adjusted EBITDA guidance raised to $605 million to $615 million.
Community Living divestiture to Sevita is expected to close in early Q1 2026; full Q3 results and conference call on October 28, 2025.
Crown Holdings reported third quarter 2025 results, with net sales of $3,202 million, up from $3,074 million a year earlier, and diluted earnings per share of $1.85 versus a diluted loss of $1.47 in 2024. The company raised its full-year 2025 adjusted diluted EPS guidance to $7.70 to $7.80 and reported it had reached its 2.5x adjusted net leverage target, which matters to shareholders because the company also returned more than $400 million to shareholders in the first nine months through buybacks and dividends.
Q3 adjusted diluted EPS rose 13% to $2.24 from $1.99; income from operations fell to $423 million from $444 million
Full-year 2025 adjusted diluted EPS guidance raised to $7.70 to $7.80; fourth quarter adjusted EPS expected at $1.65 to $1.75
Expected 2025 adjusted free cash flow of approximately $1.0 billion after capital spending of approximately $400 million
Adjusted net leverage ratio reached 2.5x at September 30, 2025, the company's long-term target
MillerKnoll appointed Kevin Veltman as Chief Financial Officer on October 16, 2025, ending his interim role that began September 8, 2025. His base salary rose to $520,000, and he received a one-time long-term equity award valued at $500,000, which ties part of his pay to performance share units.
Veltman was appointed CFO on October 16, 2025, after serving as interim CFO from September 8, 2025.
Base salary increased to $520,000; fiscal 2026 annual incentive target set at 75% of base salary.
One-time long-term equity award valued at $500,000, split 50% performance share units and 50% restricted stock units.
Former CFO Jeff Stutz transitioned to Chief Operating Officer.
Flagstar Financial merged into its subsidiary, Flagstar Bank, N.A., which is now the publicly traded parent and continues under the ticker FLG on the NYSE from October 20, 2025. The filing says the reorganization simplifies the corporate structure and that it has no impact on client accounts, services or day-to-day operations, with existing shares converted one-for-one into the bank's shares.
Reorganization completed October 17, 2025; Flagstar Bank, N.A. is now the surviving public company
Common and Series A preferred shares converted into an equal number of bank shares, par value $0.01
Bank assumed Predecessor's 5.90% notes due 2028, 4.125% notes due 2030 and junior subordinated debentures totaling $610 million outstanding at September 30, 2025
Stock trades on NYSE under FLG beginning October 20, 2025
ChampionsGate Acquisition Corporation, a blank check company, appointed Boon Liat Timothy Lim as Chairman, CEO and director, effective immediately, after the board decided on October 17, 2025. He succeeds Bala Padmakumar, who resigned from all positions on July 31, 2025. Lim's offer letter provides $13,250 when the company signs a definitive agreement with a target company and another $13,250 when it completes an initial business combination.
Board appointed Lim as Chairman, CEO and director on October 17, 2025, effective immediately.
Lim succeeds Bala Padmakumar, who resigned all positions effective July 31, 2025.
Offer letter pays $13,250 on signing a definitive target agreement and another $13,250 on completing an initial business combination.
Company issued a press release on October 20, 2025 announcing the appointment; the filing reports no financial results.
Huntington Bancshares closed its acquisition of Veritex Holdings, a Dallas-based bank holding company, on October 20, 2025. Veritex shareholders received 1.95 Huntington shares for each Veritex share, and the combined company reports about $223 billion in assets.
Each Veritex common share converted into 1.95 Huntington common shares, with cash paid in lieu of fractional shares.
The combined company has about $223 billion in assets, $176 billion in deposits and $148 billion in loans, based on September 30, 2025 balances.
Veritex customer accounts will convert to Huntington's systems in the first quarter of 2026.
Veritex CEO C. Malcolm Holland III joins Huntington in a non-executive role as Chairman of Texas.
STAAR Surgical released preliminary third-quarter 2025 net sales of $94.7 million, up 6.9% from $88.6 million a year earlier, ahead of its October 23, 2025 stockholder vote on the Alcon merger proposal. The increase relied heavily on a $25.9 million December 2024 China shipment paid in full in the quarter, while distributor orders in China fell and nine-month sales declined year over year. The figures are unaudited and subject to change before the 10-Q is filed.
Q3 2025 preliminary net sales of $94.7 million, up 6.9% from $88.6 million
$25.9 million from the December 2024 China shipment was recognized in Q3 2025 after payment in full
Net sales outside China grew 7.7%, while new orders from China distributors were lower
Nine-month 2025 sales were lower than the prior year, as China distributors reduced inventory by about $80 million to $85 million
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.